-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
SpringWorks Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q1 2025.
- SpringWorks Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2025 was 74.9M shares, a 1.51% increase year-over-year.
- SpringWorks Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 74.1M shares, a 17.4% increase from 2023.
- SpringWorks Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 63.1M shares, a 18.5% increase from 2022.
- SpringWorks Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 53.3M shares, a 9.88% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)